Power Wheelchair Group 3 denied as duplicate or overlapping therapy by Humana?

Humana's specific coverage criteria for power wheelchair group3 are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denied a Power Wheelchair Group 3 as Duplicate Therapy — and How to Appeal

Humana may issue a duplicate-therapy denial for a Group 3 complex rehab power wheelchair when records show an existing power mobility device is already on file for the member. Humana's DME policy generally limits members to one power mobility device at a time, and a new request without adequate explanation of why the existing device no longer meets clinical needs will be flagged as duplicative.

## Why This Denial Is Appealable

A duplicate-therapy denial is not a finding that you do not need a wheelchair — it is a finding that you already have one. The appeal reframes the question: the existing device no longer adequately serves your documented clinical need, either because of functional change, equipment failure, or the prior device's inability to accommodate a new or worsening condition. Group 3 complex rehab technology is specifically designed for individuals whose needs cannot be met by standard Group 2 devices, which is itself a clinical distinction.

## Federal Appeal Framework

• Internal appeal: File within the timeframe on your EOB. Humana's standard pre-service decision window is 30 days; post-service claims allow 60 days; expedited requests (urgent need) are 72 hours.
• External review (ACA §2719): If Humana upholds the denial internally, you are entitled to independent external review. File within approximately four months of the final denial. The IRO decision binds Humana.
• ERISA §503: If covered under an employer plan, you have the right to a full-and-fair review and access to all documents Humana relied on. Request the complete claim file.
• Expedited review: Available if the standard timeline would seriously jeopardize your health or functional capacity.

## Documentation to Gather

• Current device records: Documentation of your existing wheelchair — model, age, condition, repair history — and why it no longer meets your needs.
• Functional change documentation: Chart notes demonstrating a new diagnosis, progression of existing condition, or change in functional status since the current device was issued.
• Group 3 clinical justification: Evaluation by a qualified rehab technology supplier and a physical or occupational therapist confirming that your needs now require Group 3 complex rehab features not present in your current device.
• Prescribing physician letter: A medical necessity letter explicitly stating why the prior device is insufficient and why Group 3 is now required.
• Humana's DME coverage policy: Obtain the current policy and identify the exception provisions for equipment upgrade due to changed clinical need.

## Criteria-Mapping Structure

For each element Humana cites as duplicative, provide a direct clinical counter-entry: the date your functional status changed, the provider who documented it, and the specific feature of the Group 3 device that the current device lacks. Frame the appeal as a substitution driven by clinical need escalation, not an addition — that is the argument most likely to succeed.